
### [MONDO:0002229](http://purl.obolibrary.org/obo/MONDO_0002229)
**Label:** ovarian epithelial tumor

**Subclasses:** [MONDO:0016247](http://purl.obolibrary.org/obo/MONDO_0016247) (malignant mixed mullerian tumor of the ovary), [MONDO:0013253](http://purl.obolibrary.org/obo/MONDO_0013253) (breast-ovarian cancer, familial, susceptibility to, 3), [MONDO:0003922](http://purl.obolibrary.org/obo/MONDO_0003922) (ovarian clear cell malignant adenofibroma), [MONDO:0002830](http://purl.obolibrary.org/obo/MONDO_0002830) (ovary transitional cell carcinoma), [MONDO:0004535](http://purl.obolibrary.org/obo/MONDO_0004535) (childhood choriocarcinoma of the ovary), [MONDO:0003049](http://purl.obolibrary.org/obo/MONDO_0003049) (ovarian large-cell neuroendocrine carcinoma), [MONDO:0002752](http://purl.obolibrary.org/obo/MONDO_0002752) (ovary adenocarcinoma), [MONDO:0004136](http://purl.obolibrary.org/obo/MONDO_0004136) (ovarian endometrioid cystadenoma), [MONDO:0006477](http://purl.obolibrary.org/obo/MONDO_0006477) (undifferentiated ovarian carcinoma), [MONDO:0004294](http://purl.obolibrary.org/obo/MONDO_0004294) (gestational ovarian choriocarcinoma), [MONDO:0005183](http://purl.obolibrary.org/obo/MONDO_0005183) (ovarian cystadenoma), [MONDO:0005140](http://purl.obolibrary.org/obo/MONDO_0005140) (ovarian carcinoma), [MONDO:0004829](http://purl.obolibrary.org/obo/MONDO_0004829) (Krukenberg carcinoma), [MONDO:0003813](http://purl.obolibrary.org/obo/MONDO_0003813) (ovarian papillary tumor), [MONDO:0000548](http://purl.obolibrary.org/obo/MONDO_0000548) (ovarian clear cell cancer), [MONDO:0018691](http://purl.obolibrary.org/obo/MONDO_0018691) (endometrioid carcinoma of ovary), [MONDO:0003812](http://purl.obolibrary.org/obo/MONDO_0003812) (ovarian endometrial cancer), [MONDO:0003610](http://purl.obolibrary.org/obo/MONDO_0003610) (rete ovarii cystadenoma), [MONDO:0003495](http://purl.obolibrary.org/obo/MONDO_0003495) (ovarian squamous cell neoplasm), [MONDO:0004222](http://purl.obolibrary.org/obo/MONDO_0004222) (ovarian clear cell cystadenocarcinoma), [MONDO:0021144](http://purl.obolibrary.org/obo/MONDO_0021144) (ovarian clear cell tumor), [MONDO:0006046](http://purl.obolibrary.org/obo/MONDO_0006046) (ovarian serous cystadenocarcinoma), [MONDO:0002880](http://purl.obolibrary.org/obo/MONDO_0002880) (ovarian mesodermal adenosarcoma), [MONDO:0003494](http://purl.obolibrary.org/obo/MONDO_0003494) (ovarian squamous cell carcinoma), [MONDO:0006045](http://purl.obolibrary.org/obo/MONDO_0006045) (ovarian clear cell adenocarcinoma), [MONDO:0018368](http://purl.obolibrary.org/obo/MONDO_0018368) (primary peritoneal serous/papillary carcinoma), [MONDO:0011450](http://purl.obolibrary.org/obo/MONDO_0011450) (breast-ovarian cancer, familial, susceptibility to, 1), [MONDO:0018366](http://purl.obolibrary.org/obo/MONDO_0018366) (mucinous adenocarcinoma of ovary), [MONDO:0003507](http://purl.obolibrary.org/obo/MONDO_0003507) (choriocarcinoma of ovary), [MONDO:0018364](http://purl.obolibrary.org/obo/MONDO_0018364) (malignant epithelial tumor of ovary), [MONDO:0004319](http://purl.obolibrary.org/obo/MONDO_0004319) (hypercalcemic type ovarian small cell carcinoma), [MONDO:0003625](http://purl.obolibrary.org/obo/MONDO_0003625) (ovary serous adenocarcinoma), [MONDO:0004318](http://purl.obolibrary.org/obo/MONDO_0004318) (pulmonary type ovarian small cell carcinoma), [MONDO:0005601](http://purl.obolibrary.org/obo/MONDO_0005601) (ovarian mucinous adenocarcinoma), [MONDO:0006335](http://purl.obolibrary.org/obo/MONDO_0006335) (ovarian endometrioid adenocarcinoma), [MONDO:0003581](http://purl.obolibrary.org/obo/MONDO_0003581) (ovarian embryonal carcinoma), [MONDO:0004033](http://purl.obolibrary.org/obo/MONDO_0004033) (familial ovarian carcinoma), [MONDO:0004031](http://purl.obolibrary.org/obo/MONDO_0004031) (ovary mixed epithelial carcinoma), [MONDO:0015442](http://purl.obolibrary.org/obo/MONDO_0015442) (hereditary breast and ovarian cancer syndrome), [MONDO:0003839](http://purl.obolibrary.org/obo/MONDO_0003839) (ovarian mucinous malignant adenofibroma), [MONDO:0002702](http://purl.obolibrary.org/obo/MONDO_0002702) (ovarian cystadenocarcinoma), [MONDO:0003879](http://purl.obolibrary.org/obo/MONDO_0003879) (ovarian endometrioid malignant adenofibroma), [MONDO:0003756](http://purl.obolibrary.org/obo/MONDO_0003756) (ovarian mucinous neoplasm), [MONDO:0002701](http://purl.obolibrary.org/obo/MONDO_0002701) (ovarian mucinous cystadenocarcinoma), [MONDO:0016093](http://purl.obolibrary.org/obo/MONDO_0016093) (borderline epithelial tumor of ovary), [MONDO:0004005](http://purl.obolibrary.org/obo/MONDO_0004005) (rete ovarii adenoma), [MONDO:0003873](http://purl.obolibrary.org/obo/MONDO_0003873) (ovarian surface papilloma), [MONDO:0003874](http://purl.obolibrary.org/obo/MONDO_0003874) (ovary papillary carcinoma), [MONDO:0004322](http://purl.obolibrary.org/obo/MONDO_0004322) (non-gestational ovarian choriocarcinoma), [MONDO:0003795](http://purl.obolibrary.org/obo/MONDO_0003795) (ovarian small cell carcinoma), [MONDO:0003872](http://purl.obolibrary.org/obo/MONDO_0003872) (ovarian papillary cystadenoma), [MONDO:0003792](http://purl.obolibrary.org/obo/MONDO_0003792) (ovarian carcinosarcoma), [MONDO:0004441](http://purl.obolibrary.org/obo/MONDO_0004441) (childhood ovarian embryonal carcinoma), [MONDO:0002583](http://purl.obolibrary.org/obo/MONDO_0002583) (mucinous ovarian cystadenoma), [MONDO:0006343](http://purl.obolibrary.org/obo/MONDO_0006343) (ovarian transitional cell carcinoma), [MONDO:0013669](http://purl.obolibrary.org/obo/MONDO_0013669) (breast-ovarian cancer, familial, susceptibility to, 4), [MONDO:0003191](http://purl.obolibrary.org/obo/MONDO_0003191) (rete ovarii adenocarcinoma), [MONDO:0012933](http://purl.obolibrary.org/obo/MONDO_0012933) (breast-ovarian cancer, familial, susceptibility to, 2), 

**Mapped go classes:** [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0007098](http://purl.obolibrary.org/obo/GO_0007098) (centrosome cycle), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0070200](http://purl.obolibrary.org/obo/GO_0070200) (establishment of protein localization to telomere), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0009048](http://purl.obolibrary.org/obo/GO_0009048) (dosage compensation by inactivation of X chromosome), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001556](http://purl.obolibrary.org/obo/GO_0001556) (oocyte maturation), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0001833](http://purl.obolibrary.org/obo/GO_0001833) (inner cell mass cell proliferation), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0010484](http://purl.obolibrary.org/obo/GO_0010484) (H3 histone acetyltransferase activity), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0006301](http://purl.obolibrary.org/obo/GO_0006301) (postreplication repair), [GO:0000794](http://purl.obolibrary.org/obo/GO_0000794) (condensed nuclear chromosome), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0070063](http://purl.obolibrary.org/obo/GO_0070063) (RNA polymerase binding), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:0031619](http://purl.obolibrary.org/obo/GO_0031619) (homologous chromosome orientation involved in meiotic metaphase I plate congression), [GO:1990426](http://purl.obolibrary.org/obo/GO_1990426) (mitotic recombination-dependent replication fork processing), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:0045717](http://purl.obolibrary.org/obo/GO_0045717) (negative regulation of fatty acid biosynthetic process), [GO:0033593](http://purl.obolibrary.org/obo/GO_0033593) (BRCA2-MAGE-D1 complex), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0043015](http://purl.obolibrary.org/obo/GO_0043015) (gamma-tubulin binding), [GO:0000722](http://purl.obolibrary.org/obo/GO_0000722) (telomere maintenance via recombination), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0085020](http://purl.obolibrary.org/obo/GO_0085020) (protein K6-linked ubiquitination), [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0007059](http://purl.obolibrary.org/obo/GO_0007059) (chromosome segregation), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0072425](http://purl.obolibrary.org/obo/GO_0072425) (signal transduction involved in G2 DNA damage checkpoint), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0031436](http://purl.obolibrary.org/obo/GO_0031436) (BRCA1-BARD1 complex), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0010212](http://purl.obolibrary.org/obo/GO_0010212) (response to ionizing radiation), [GO:0045739](http://purl.obolibrary.org/obo/GO_0045739) (positive regulation of DNA repair), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0000793](http://purl.obolibrary.org/obo/GO_0000793) (condensed chromosome), [GO:0071681](http://purl.obolibrary.org/obo/GO_0071681) (cellular response to indole-3-methanol), [GO:0051574](http://purl.obolibrary.org/obo/GO_0051574) (positive regulation of histone H3-K9 methylation), [GO:0051572](http://purl.obolibrary.org/obo/GO_0051572) (negative regulation of histone H3-K4 methylation), [GO:0051298](http://purl.obolibrary.org/obo/GO_0051298) (centrosome duplication), [GO:0051573](http://purl.obolibrary.org/obo/GO_0051573) (negative regulation of histone H3-K9 methylation), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0051571](http://purl.obolibrary.org/obo/GO_0051571) (positive regulation of histone H3-K4 methylation), [GO:0070512](http://purl.obolibrary.org/obo/GO_0070512) (positive regulation of histone H4-K20 methylation), [GO:0010225](http://purl.obolibrary.org/obo/GO_0010225) (response to UV-C), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0033600](http://purl.obolibrary.org/obo/GO_0033600) (negative regulation of mammary gland epithelial cell proliferation), [GO:0035066](http://purl.obolibrary.org/obo/GO_0035066) (positive regulation of histone acetylation), [GO:0043967](http://purl.obolibrary.org/obo/GO_0043967) (histone H4 acetylation), [GO:0035067](http://purl.obolibrary.org/obo/GO_0035067) (negative regulation of histone acetylation), [GO:0043966](http://purl.obolibrary.org/obo/GO_0043966) (histone H3 acetylation), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0044818](http://purl.obolibrary.org/obo/GO_0044818) (mitotic G2/M transition checkpoint), [GO:0000910](http://purl.obolibrary.org/obo/GO_0000910) (cytokinesis), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:2000617](http://purl.obolibrary.org/obo/GO_2000617) (positive regulation of histone H3-K9 acetylation), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0032465](http://purl.obolibrary.org/obo/GO_0032465) (regulation of cytokinesis), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0000800](http://purl.obolibrary.org/obo/GO_0000800) (lateral element), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:0000400](http://purl.obolibrary.org/obo/GO_0000400) (four-way junction DNA binding), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0044030](http://purl.obolibrary.org/obo/GO_0044030) (regulation of DNA methylation), [GO:0006349](http://purl.obolibrary.org/obo/GO_0006349) (regulation of gene expression by genetic imprinting), [GO:0048478](http://purl.obolibrary.org/obo/GO_0048478) (replication fork protection), [GO:0048476](http://purl.obolibrary.org/obo/GO_0048476) (Holliday junction resolvase complex), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:2000620](http://purl.obolibrary.org/obo/GO_2000620) (positive regulation of histone H4-K16 acetylation), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0070531](http://purl.obolibrary.org/obo/GO_0070531) (BRCA1-A complex), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 54.04%
- [GO:0070531](http://purl.obolibrary.org/obo/GO_0070531) (BRCA1-A complex) 51.25%
- [GO:0051455](http://purl.obolibrary.org/obo/GO_0051455) (attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation) 51.25%
- [GO:0051316](http://purl.obolibrary.org/obo/GO_0051316) (attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation) 51.25%
- [GO:0048476](http://purl.obolibrary.org/obo/GO_0048476) (Holliday junction resolvase complex) 51.25%
- [GO:0048232](http://purl.obolibrary.org/obo/GO_0048232) (male gamete generation) 51.25%
- [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth) 51.25%
- [GO:0033593](http://purl.obolibrary.org/obo/GO_0033593) (BRCA2-MAGE-D1 complex) 51.25%
- [GO:0031619](http://purl.obolibrary.org/obo/GO_0031619) (homologous chromosome orientation involved in meiotic metaphase I plate congression) 51.25%
- [GO:0031436](http://purl.obolibrary.org/obo/GO_0031436) (BRCA1-BARD1 complex) 51.25%
- [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis) 51.25%
- [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I) 51.25%
- [GO:0007140](http://purl.obolibrary.org/obo/GO_0007140) (male meiotic nuclear division) 51.25%
- [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix) 51.25%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 51.25%


